Starbucks Corporation (NASDAQ:SBUX) shares increased 1.25% in last trading session and ended the day at $57.67. SBUX Gross Margin is 31.20% and its has a return on assets of 27.30%. Starbucks Corporation (NASDAQ:SBUX) quarterly performance is -4.45%.
Starbucks Corporation (NASDAQ:SBUX) said that, express store in Canada opened in Toronto’s Union Station, which welcomes 250,000 commuters each day, with hundreds disembarking trains at the same time.
ConocoPhillips (NYSE:COP) shares fell -2.46% in last trading session and ended the day at $32.87. COP Gross Margin is 33.80% and its has a return on assets of -4.00%. ConocoPhillips (NYSE:COP) quarterly performance is -38.54%.
ConocoPhillips (NYSE:COP) said it is lowering its dividend to 25 cents per share from 74 cents per share. The dividend is payable on March 1 to shareholders of record on Feb. 16. The company also reduced its 2016 capital expenditures outlook and operating cost guidance.
The Coca-Cola Company (NYSE:KO) caters to the Consumer Goods space. It has a net profit margin of 16.60% and weekly performance is 3.21%. On the last day of trading company shares ended up at $43.77. The Coca-Cola Company (NYSE:KO) distance from 50-day simple moving average (SMA50) is 2.66%.
On 9 Februay, The Coca-Cola Company (NYSE:KO) said it would refranchise all its North America bottling operations by the end of 2017, three years earlier than expected, and also refranchise its bottling operations in China.
Biotie Therapies Corp. (NASDAQ:BITI) shares fell -0.37% in last trading session and ended the day at $24.41. Biotie Therapies Corp. (NASDAQ:BITI) quarterly performance is 83.95%.
Roth Capital cut shares of Biotie Therapies Corp. (NASDAQ:BITI) from a buy rating to a neutral rating in a research report published on Tuesday morning, Market Beat reports.
Editas Medicine Inc. (NASDAQ:EDIT) caters to the Healthcare space. Its weekly performance is 17.18%. On the last day of trading company shares ended up at $18.48. Editas Medicine Inc. (NASDAQ:EDIT) distance from 50-day simple moving average (SMA50) is -7.43%.
Editas Medicine Inc. (NASDAQ:EDIT) is poised to become the first company to go public in the United States this year after selling $94.4 million in stock on Tuesday. But the initial public offering, sealed on a day when stocks fell sharply, came at a cost: the Cambridge biotech company priced the shares at $16 apiece, at the bottom of its anticipated range of $16 to $18. Editas sold 5.9 million shares.